trazodone has been researched along with mdl 100907 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Balsara, JJ; Gaikwad, RV; Gaonkar, RK; Jadhav, JH; Jadhav, SA | 1 |
| Fava, M; Papakostas, GI | 1 |
| Papakostas, GI; Shelton, RC | 1 |
| Rosso, AL; Vincent, MB; Werneck, AL | 1 |
| Ali, AS; Ali, SA; Salim, S | 1 |
| Da Pozzo, E; Daniele, S; Martini, C; Zappelli, E | 1 |
2 review(s) available for trazodone and mdl 100907
| Article | Year |
|---|---|
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Topics: Depressive Disorder, Major; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Trazodone; Triazoles | 2007 |
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
1 trial(s) available for trazodone and mdl 100907
| Article | Year |
|---|---|
The use of an antagonist 5-HT2a/c for depression and motor function in Parkinson' disease.
Topics: Aged; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Trazodone; Treatment Outcome | 2009 |
4 other study(ies) available for trazodone and mdl 100907
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Catalepsy; Dopamine; Dopamine D2 Receptor Antagonists; Male; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stereotyped Behavior; Trazodone | 2005 |
5-HT receptor subtypes as key targets in mediating pigment dispersion within melanophores of teleost, Oreochromis mossambicus.
Topics: Allylbenzene Derivatives; Animals; Benzyl Compounds; Dioxolanes; Dose-Response Relationship, Drug; Fish Proteins; Fluoxetine; Melanins; Melanophores; Metergoline; Pigments, Biological; Pyrogallol; Receptors, Serotonin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sumatriptan; Tilapia; Trazodone; Yohimbine | 2013 |
Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK.
Topics: Anti-Inflammatory Agents; Apoptosis; Brain-Derived Neurotrophic Factor; Cell Line; Cell Proliferation; Cell Survival; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Time Factors; Trazodone; Tumor Necrosis Factor-alpha | 2015 |